Rheumnow Podcast

Burnout #10 (2.2.2023)

Dr. Jack Cush reviews the past week of news on RheumNow.com

Simon Says “Don’t Do This” (1.27.2023)

Dr. Jack Cush reviews this weeks journal articles, focuses on studies that should not have been done and responds to viewer questions in Ask Cush Anything

The RheuNow Podcast Preview - Til Death Do Us Part (1.20.2023)

Dr. Jack Cush reviews the highlights from the past week on RheumNow.com

Rheum Believe it Or Not (1.13.2023)

Dr. Jack Cush reviews the notable standouts in the news since the 1st of January.  Surprising reports on ferritin, alcohol benefits, cannabis for pain and a lower dementia risk with hydroxychloroquine.

RheumNow Podcast- 2022 Rheumatology Year in Review

Dr. Jack Cush Reviews the highlight from 2022 in Rheumatology 
Check out the full podcast at RheumNow.com

Fever, FROST, & Pericarditis (12.16.2022)

Dr. Jack Frost reviews the news and journal reports with a bonus audience question at the end.

Biosimilar Bonanza in 2023 (12.9.2022)

Dr. Jack Cush reviews the news and journal articles from this past week on RheumNow.com

Rheum Manpower Needs - More Programs! (12.2.2022)

Dr. Jack Cush reviews the news and journal articles from the past week on RheumNow.com

Biologics in Lupus – Why, Who, and When? Sponsored by GSK US Medical Affairs

Leading experts from the SLE Educators’ Network discuss how biologic therapies may help address key unmet needs in lupus, while highlighting how clinicians can identify the most appropriate patients for biologic treatment.

Topic Podcasts - JAK_TYK2

ACR22 Year in Review Report
Deucravacitinib in PsA
JAK inhibitors in rheumatic diseases
JAK vs TNF inhibitor Infections in RA
New Treatments for SLE?
Prelude to a Meeting (ACR22) (11.11.2022)
Switching Between JAK Inhibiters in RA
Tapering Methotrexate with Biologics or JAK Inhibitors in RA
Tofacitinib and RA-ILD
Upadacitinib vs Adalimumab in PsA using RAPID3